Zinc prevents the copper-induced damage of cultured astrocytes

Neurochemistry International

Volumn 57, Issue 3, 2010, Pages 314-322

  Scheiber, Ivo F ^a   Schmidt, Maike M ^a   Dringen, Ralf ^a,b  

^a UNIVERSITY OF BREMEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Copper; Glutathione; Membrane permeability; Oxidative stress; Propidium iodide; Zinc

Indexed keywords

COPPER CHLORIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ZINC CHLORIDE; CHLORIDE; COPPER; NERVE PROTEIN; REACTIVE OXYGEN METABOLITE; ZINC DERIVATIVE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; LIPID PEROXIDATION; MEMBRANE PERMEABILITY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; METABOLISM; TOXICITY; WISTAR RAT;

ANIMALS; ASTROCYTES; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHLORIDES; COPPER; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ZINC COMPOUNDS;

EID: 77955092432     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.06.010     Document Type: Article

References (55)

1. Aschner M., Cherian M.G., Klaassen C.D., Palmiter R.D., Erickson J.C., Bush A.I. Metallothioneins in brain-the role in physiology and pathology. Toxicol. Appl. Pharmacol. 1997, 142:229-242.
2. Balamurugan K., Schaffner W. Copper homeostasis in eukaryotes: teetering on a tightrope. Biochim. Biophys. Acta 2006, 1763:737-746.
3. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80:1326-1338.
4. Bishop G.M., Dringen R., Robinson S.R. Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic. Biol. Med. 2007, 42:1222-1230.
5. Boulard M., Blume K.G., Beutler E. The effect of copper on red cell enzyme activities. J. Clin. Invest. 1972, 51:459-461.
6. Britton R.S. Metal-induced hepatotoxicity. Semin. Liver Dis. 1996, 16:3-12.
7. Brown D.R. Role of the prion protein in copper turnover in astrocytes. Neurobiol. Dis. 2004, 15:534-543.
8. Burkitt M.J. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch. Biochem. Biophys. 2001, 394:117-135.
9. Deutsch J. Glucose-6-phosphate dehydrogenase. Methods of Enzymatic Analysis 1984, vol. 3. Verlag Chemie, Weinheim, pp. 190-197.
10. Dineley K.E., Scanlon J.M., Kress G.J., Stout A.K., Reynolds I.J. Astrocytes are more resistant than neurons to the cytotoxic effects of increased [Zn(2+)](i). Neurobiol. Dis. 2000, 7:310-320.
11. Ding W.Q., Liu B., Vaught J.L., Palmiter R.D., Lind S.E. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol. Cancer. Ther. 2006, 5:1864-1872.
12. Dringen R., Hamprecht B. Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J. Neurochem. 1996, 67:1375-1382.
13. Dringen R., Hamprecht B. Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev. Neurosci. 1998, 20:401-407.
14. Dringen R., Kranich O., Hamprecht B. The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 1997, 22:727-733.
15. Dringen R., Kussmaul L., Hamprecht B. Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Res. Brain Res. Protoc. 1998, 2:223-228.
16. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab. Brain. Dis. 2004, 19:229-239.
17. Ferretti G., Bacchetti T., Moroni C., Vignini A., Curatola G. Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim. Biophys. Acta 2003, 1635:48-54.
18. Gaeta A., Hider R.C. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br. J. Pharmacol. 2005, 146:1041-1059.
19. Gunther M.R., Hanna P.M., Mason R.P., Cohen M.S. Hydroxyl radical formation from cuprous ion and hydrogen peroxide: a spin-trapping study. Arch. Biochem. Biophys. 1995, 316:515-522.
20. Gutterer J.M., Dringen R., Hirrlinger J., Hamprecht B. Purification of glutathione reductase from bovine brain, generation of an antiserum, and immunocytochemical localization of the enzyme in neural cells. J. Neurochem. 1999, 73:1422-1430.
21. Gyulkhandanyan A.V., Feeney C.J., Pennefather P.S. Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes. J. Neurochem. 2003, 87:448-460.
22. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13:54-63.
23. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990, 186:1-85.
24. Hamprecht B., Loffler F. Primary glial cultures as a model for studying hormone action. Methods Enzymol. 1985, 109:341-345.
25. Haydon P.G., Blendy J., Moss S.J., Rob Jackson F. Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?. Neuropharmacology 2009, 56(Suppl 1):83-90.
26. Haywood S., Paris J., Ryvar R., Botteron C. Brain copper elevation and neurological changes in north ronaldsay sheep: a model for neurodegenerative disease?. J. Comp. Pathol. 2008, 139:252-255.
27. Hirrlinger, J., Dringen, R., 2010. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev., 63, 177-188.
28. Hoepken H.H., Korten T., Robinson S.R., Dringen R. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J. Neurochem. 2004, 88:1194-1202.
29. Hopt A., Korte S., Fink H., Panne U., Niessner R., Jahn R., Kretzschmar H., Herms J. Methods for studying synaptosomal copper release. J. Neurosci. Methods 2003, 128:159-172.
30. Huster D., Lutsenko S. Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism. Mol. Biosyst. 2007, 3:816-824.
31. Kardos J., Kovacs I., Hajos F., Kalman M., Simonyi M. Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability. Neurosci. Lett. 1989, 103:139-144.
32. Lee J., Petris M.J., Thiele D.J. Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J. Biol. Chem. 2002, 277:40253-40259.
33. Letelier M.E., Martinez M., Gonzalez-Lira V., Faundez M., Aracena-Parks P. Inhibition of cytosolic glutathione S-transferase activity from rat liver by copper. Chem. Biol. Interact. 2006, 164:39-48.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
35. Macreadie I.G. Copper transport and Alzheimer's disease. Eur. Biophys. J. 2008, 37:295-300.
36. Medici V., Rossaro L., Sturniolo G.C. Wilson disease-a practical approach to diagnosis, treatment and follow-up. Dig. Liver Dis. 2007, 39:601-609.
37. Mercer J.F. The molecular basis of copper-transport diseases. Trends Mol. Med. 2001, 7:64-69.
38. Merker K., Hapke D., Reckzeh K., Schmidt H., Lochs H., Grune T. Copper related toxic effects on cellular protein metabolism in human astrocytes. Biofactors 2005, 24:255-261.
39. Muller T., Muller W., Feichtinger H. Idiopathic copper toxicosis. Am. J. Clin. Nutr. 1998, 67:1082S-1086S.
40. Muyderman H., Wadey A.L., Nilsson M., Sims N.R. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes. J. Neurochem. 2007, 102:1369-1382.
41. Nalbandyan R.M. Copper in brain. Neurochem. Res. 1983, 8:1211-1232.
42. Pamp K., Bramey T., Kirsch M., De Groot H., Petrat F. NAD(H) enhances the Cu(II)-mediated inactivation of lactate dehydrogenase by increasing the accessibility of sulfhydryl groups. Free Radic. Res. 2005, 39:31-40.
43. Pfeiffer R.F. Wilson's Disease. Semin. Neurol. 2007, 27:123-132.
44. Pope S.A., Milton R., Heales S.J. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem. Res. 2008, 33:1410-1418.
45. Reddy P.V., Rao K.V., Norenberg M.D. The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab. Invest. 2008, 88:816-830.
46. Rossi L., Lombardo M.F., Ciriolo M.R., Rotilio G. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem. Res. 2004, 29:493-504.
47. Scheiber I.F., Mercer J.F.B., Dringen R. Copper accumulation in cultured astrocytes. Neurochem. Int. 2010, 56:451-460.
48. Schilsky M.L., Blank R.R., Czaja M.J., Zern M.A., Scheinberg I.H., Stockert R.J., Sternlieb I. Hepatocellular copper toxicity and its attenuation by zinc. J. Clin. Invest. 1989, 84:1562-1568.
49. Schwerdtle T., Hamann I., Jahnke G., Walter I., Richter C., Parsons J.L., Dianov G.L., Hartwig A. Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol. Nutr. Food Res. 2007, 51:201-210.
50. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48:4827-4833.
51. Singh R.P., Kumar S., Nada R., Prasad R. Evaluation of copper toxicity in isolated human peripheral blood mononuclear cells and it's attenuation by zinc: ex vivo. Mol. Cell. Biochem. 2006, 282:13-21.
52. Strausak D., Mercer J.F., Dieter H.H., Stremmel W., Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res. Bull. 2001, 55:175-185.
53. Tanner M.S. Role of copper in Indian childhood cirrhosis. Am. J. Clin. Nutr. 1998, 67:1074S-1081S.
54. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969, 27:502-522.
55. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 1999, 6:221-230.